Abstract
ObjectiveInterleukin 6 (IL-6) receptor (IL-6R) inhibition by tocilizumab is a novel anti-inflammatory therapy for rheumatoid arthritis (RA) patients. As IL-6 is a late differentiation factor of B cells the authors...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have